1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 13 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort studyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J.
2015Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseMoore, O.A.; Proudman, S.M.; Goh, N.; Corte, T.J.; Rouse, H.; Hennessy, O.; Morrisroe, K.; Thakkar, V.; Sahhar, J.; Roddy, J.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.; 2013 ACR/ARHP Annual Meeting (25 Oct 2013 - 30 Oct 2013 : San Diego, CA)
2013Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseMoore, O.; Proudman, S.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Thakkar, V.; Sahhar, J.; Roddy, J.E.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.; 2013 ACR/ARHP Annual Meeting (25 Oct 2013 - 30 Oct 2013 : San Diego, CA)
2017A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adultsMorrisroe, K.; Stevens, W.; Proudman, S.; Nikpour, M.
2020Incidence, risk factors and outcomes of cancer in systemic sclerosisMorrisroe, K.; Hansen, D.; Huq, M.; Stevens, W.; Sahhar, J.; Ngian, G.-S.; Ferdowsi, N.; Hill, C.; Roddy, J.; Walker, J.; Proudman, S.; Nikpour, M.
2019Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): A novel instrument to quantify organ damage in systemic sclerosisFerdowsi, N.; Huq, M.; Stevens, W.; Hudson, M.; Wang, M.; Tay, T.; Burchell, J.L.; Mancuso, S.; Rabusa, C.; Sundararajan, V.; Prior, D.; Proudman, S.M.; Baron, M.; Nikpour, M.
2021Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patientsLee, A.; Patterson, K.A.; Tan, D.J.; Wilson, M.E.; Proudman, S.M.; Stevens, W.; Nikpour, M.; Sahhar, J.; Ngian, G.-S.; Roddy, J.; Roberts-Thomson, P.J.; Walker, J.G.
2023Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.Fairley, J.L.; Hansen, D.; Ross, L.; Proudman, S.; Sahhar, J.; Ngian, G.-S.; Walker, J.; Host, L.V.; Morrisroe, K.; Apostolopoulous, D.; Ferdowsi, N.; Wilson, M.; Tabesh, M.; Stevens, W.; Nikpour, M.; Australian Scleroderma Interest Group,
2022Evaluation of patient and physician assessments of gastrointestinal disease activity in systemic sclerosisRoss, L.; Proudman, S.; Walker, J.; Stevens, W.; Ferdowsi, N.; Quinlivan, A.; Morrisroe, K.; Baron, M.; Nikpour, M.
2022Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survivalMorrisroe, K.; Hansen, D.; Stevens, W.; Sahhar, J.; Ngian, G.S.; Hill, C.; Roddy, J.; Walker, J.; Proudman, S.; Nikpour, M.

Discover